bw a868c has been researched along with potassium chloride in 1 studies
Studies (bw a868c) | Trials (bw a868c) | Recent Studies (post-2010) (bw a868c) | Studies (potassium chloride) | Trials (potassium chloride) | Recent Studies (post-2010) (potassium chloride) |
---|---|---|---|---|---|
47 | 0 | 11 | 18,040 | 395 | 1,764 |
Protein | Taxonomy | bw a868c (IC50) | potassium chloride (IC50) |
---|---|---|---|
Sodium/potassium/calcium exchanger 4 | Homo sapiens (human) | 174000 | |
Sodium/potassium/calcium exchanger 2 | Homo sapiens (human) | 280000 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leff, P; Lydford, SJ; McKechnie, KC | 1 |
1 other study(ies) available for bw a868c and potassium chloride
Article | Year |
---|---|
Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Topics: Animals; Anti-Arrhythmia Agents; Biphenyl Compounds; Dinoprostone; Dose-Response Relationship, Drug; Hydantoins; Male; Potassium Chloride; Prostaglandin D2; Rabbits; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Saphenous Vein | 1996 |